The stock of Syra Health Corp (SYRA) has seen a -8.40% decrease in the past week, with a -55.56% drop in the past month, and a -73.26% decrease in the past quarter. The volatility ratio for the week is 6.94%, and the volatility levels for the past 30 days are at 10.00% for SYRA. The simple moving average for the past 20 days is -13.77% for SYRA’s stock, with a -72.61% simple moving average for the past 200 days.
Is It Worth Investing in Syra Health Corp (NASDAQ: SYRA) Right Now?
Additionally, the 36-month beta value for SYRA is 5.41. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SYRA is 7.44M and currently, short sellers hold a 1.71% ratio of that float. The average trading volume of SYRA on October 11, 2024 was 238.50K shares.
SYRA) stock’s latest price update
Syra Health Corp (NASDAQ: SYRA)’s stock price has dropped by -6.42 in relation to previous closing price of 0.38. Nevertheless, the company has seen a loss of -8.40% in its stock price over the last five trading days. prnewswire.com reported 2024-10-09 that CARMEL, Ind., Oct. 9, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare technology company powering better health by providing meaningful solutions, announced today more details about the award of three new healthcare workforce contracts: one in Florida, one in Kansas, and one in Delaware.
SYRA Trading at -57.74% from the 50-Day Moving Average
After a stumble in the market that brought SYRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.75% of loss for the given period.
Volatility was left at 10.00%, however, over the last 30 days, the volatility rate increased by 6.94%, as shares sank -17.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -73.06% lower at present.
During the last 5 trading sessions, SYRA fell by -8.40%, which changed the moving average for the period of 200-days by -65.81% in comparison to the 20-day moving average, which settled at $0.4124. In addition, Syra Health Corp saw -64.99% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SYRA starting from Prasad Priya, who purchase 4,271 shares at the price of $1.14 back on Dec 04 ’23. After this action, Prasad Priya now owns 8,106 shares of Syra Health Corp, valued at $4,869 using the latest closing price.
Prasad Priya, the CFO and COO of Syra Health Corp, purchase 5,303 shares at $0.38 during a trade that took place back on Sep 12 ’24, which means that Prasad Priya is holding 10,295 shares at $2,015 based on the most recent closing price.
Stock Fundamentals for SYRA
Current profitability levels for the company are sitting at:
- -0.59 for the present operating margin
- 0.11 for the gross margin
The net margin for Syra Health Corp stands at -0.59. The total capital return value is set at -1.78. Equity return is now at value -688.49, with -166.37 for asset returns.
Based on Syra Health Corp (SYRA), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -9.52. The debt to equity ratio resting at 0.22. The interest coverage ratio of the stock is -133.35.
Currently, EBITDA for the company is -2.84 million with net debt to EBITDA at 0.28. When we switch over and look at the enterprise to sales, we see a ratio of 0.33. The receivables turnover for the company is 7.14for trailing twelve months and the total asset turnover is 2.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.14.
Conclusion
In conclusion, Syra Health Corp (SYRA) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
